Edition:
United Kingdom

Tamara Mathias

RPT-FOCUS-Coronavirus outbreak begins to disrupt booming China drug trials

13 Feb 2020

Feb 12 The fast-spreading coronavirus is starting to disrupt testing of experimental medicines in China, posing a threat to plans by global drugmakers that have invested billions of dollars to harness the potential of the Asian economic powerhouse.

Coronavirus outbreak begins to disrupt booming China drug trials

12 Feb 2020

The fast-spreading coronavirus is starting to disrupt testing of experimental medicines in China, posing a threat to plans by global drugmakers that have invested billions of dollars to harness the potential of the Asian economic powerhouse.

Pregnant women with Medicaid less likely to get recommended vaccines

10 Feb 2020

Pregnant women who rely on state-administered Medicaid health insurance programs are far less likely to receive recommended vaccines that could protect them and their babies, compared to those with private coverage, a study from Florida suggests.

UPDATE 2-New drugs contribute to AbbVie's upbeat 2020 view; shares hit year-high

07 Feb 2020

Feb 7 AbbVie Inc on Friday forecast full-year earnings well above Wall Street estimates, as the U.S. drugmaker looks to new treatments and its pending acquisition of Allergan Plc to drive growth beyond 2023, when its cash cow Humira loses patent protection.

Cigna sees 2020 revenue target above estimates on Medicare Advantage growth

06 Feb 2020

Cigna Corp on Thursday forecast 2020 revenue well above Wall Street estimates on Thursday, as it expects a significant increase in the number of people signing up for its government-backed Medicare Advantage health plans.

UPDATE 2-Humana profit beats Street view on Medicare strength, provides upbeat 2020 forecast

05 Feb 2020

Feb 5 Humana Inc on Wednesday reported a higher-than-expected quarterly profit on the strength of its business that sells government-backed Medicare plans, and the U.S. health insurer forecast 2020 revenue ahead of Wall Street estimates.

Biogen gears up for potential launch of Alzheimer's drug

30 Jan 2020

Biogen Inc said on Thursday it was preparing for the launch of its experimental treatment for Alzheimer's as the drugmaker races to become the first to bring a treatment for the memory-robbing disease to market.

Anthem's growing, low-margin government business to hurt medical costs

29 Jan 2020

Anthem Inc on Wednesday warned medical costs in 2020 would be higher than market expectations as low-margin, government-backed health plans become a bigger portion of its business, sending the U.S. insurer's shares down about 6%.

Novartis wins Medicaid approval for new sickle cell drug in key U.S. states

20 Dec 2019

Novartis AG has secured Medicaid coverage for a pricey new sickle cell disease therapy in two U.S. states just weeks after winning U.S. approval, following an early campaign to convince local officials of its value, according to a company executive and a Reuters review of public filings.

World News